BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 13, 2005
View Archived Issues
Range Of Reasons For Animal Cloning: Heroic To Narcissistic
Read More
Celldex Buying Two Firms; IPO Plans Still On Horizon
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Positive Tadalafil Data In BPH Starts Phase III Plans For ICOS
Lilly ICOS LLC plans to move tadalafil into a Phase III program for benign prostatic hyperplasia after it reached statistical significance in a Phase II proof-of-concept study. (BioWorld Today)
Read More
Raven's Series D: $48M For RAV12 Cancer Trials
Read More